B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease Recurrence
- 1 May 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 179 (5) , 1954-1960
- https://doi.org/10.1016/j.juro.2008.01.056
Abstract
Purpose: Despite tremendous gains in improving prognosis, 10% of patients with Wilms tumor will ultimately experience disease recurrence. The identification of novel prognostic markers and tumor as...Keywords
This publication has 18 references indexed in Scilit:
- Treatment of Anaplastic Histology Wilms' Tumor: Results From the Fifth National Wilms' Tumor StudyJournal of Clinical Oncology, 2006
- Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-upCancer Research, 2006
- B7-H1 glycoprotein blockade: A novel strategy to enhance immunotherapy in patients with renal cell carcinomaUrology, 2005
- END STAGE RENAL DISEASE IN PATIENTS WITH WILMS TUMOR: RESULTS FROM THE NATIONAL WILMS TUMOR STUDY GROUP AND THE UNITED STATES RENAL DATA SYSTEMJournal of Urology, 2005
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetProceedings of the National Academy of Sciences, 2004
- Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunityNature Medicine, 2003
- Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- Controversies and advances in the management of Wilms' tumourArchives of Disease in Childhood, 2002
- Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- Wilms tumorCA: A Cancer Journal for Clinicians, 1996